Researchers from the University of Leeds (UK) have described a new biosensing platform for detecting biomarkers that makes use of ‘DNA origami’ – folding of DNA molecules into specific nanostructures – and nanopores to enable individual biomarker detection.
Researchers from the University of Illinois at Urbana–Champaign (IL, USA) have demonstrated a prototype of a rapid, portable SARS-CoV-2 detection system that does not require an RNA extraction kit, thereby ‘bypassing the lab’. If approved, such a device could enable point-of-care COVID-19 diagnosis.
As part of its ongoing commitment to help meet testing needs, LabCorp (NC, USA) has announced that its COVID-19 molecular testing capacity has been increased to 200,000 tests per day.
Researchers from The University of Texas (TX, USA) have explained two different types of detectable antibody responses to the SARS-CoV-2 virus that may indicate different outcomes in terms of protection against reinfection of COVID-19.
Researchers from the University of Birmingham (Birmingham, UK) and Newcastle University (Newcastle, UK) have investigated a key enzyme utilized by gut bacteria that could be developed as a biomarker for intestinal diseases.
I have the great pleasure to announce that the 24th Reid International Bioanalytical Forum will be held on the 20–23 September 2021…
PerkinElmer, Inc. (MA, USA) have described their technology and research solutions available to their global customers in the fight against COVID-19.